Ann Marie Navar, MD, PhD

Associate Professor of Medicine
Affiliate Faculty Member, Duke-Margolis Center for Health Policy
Member in the Duke Clinical Research Institute
Campus mail 2400 Pratt St., Box 3850, Durham, NC 27705
Phone (919) 684-8111
In Their Words

Education and Training

  • Cardiovascular Disease Fellowship, Duke University School of Medicine, 2013 - 2016
  • Internal Medicine and Pediatrics Residency, Duke University School of Medicine, 2009 - 2013
  • Ph.D., Johns Hopkins University, 2009
  • M.D., Duke University School of Medicine, 2009
  • M.H.S., Johns Hopkins University, 2005

Publications

Griffin, Andrew, Ann Marie Navar, Lawrence Crawford, Joseph Mammarappallil, and Lynne Hurwitz Koweek. “A case of spontaneous coronary artery dissection diagnosed by coronary computed tomography angiography.” J Cardiovasc Comput Tomogr 12, no. 1 (January 2018): 88–89. https://doi.org/10.1016/j.jcct.2017.09.005.

PMID
28935520
Full Text

Hess, Paul L., Kevin Kennedy, Michael Cowherd, Salim S. Virani, Frederick A. Masoudi, Ann Marie Navar, Robert W. Yeh, P Michael Ho, and Thomas M. Maddox. “Implications of the FDA approval of PCSK9 inhibitors and FOURIER results for contemporary cardiovascular practice: An NCDR Research to Practice (R2P) project.” Am Heart J 195 (January 2018): 151–52. https://doi.org/10.1016/j.ahj.2017.09.004.

PMID
29224643
Full Text

Pagidipati, Neha J., Matthew Phelan, Ann Marie Navar, Michael Pencina, and Eric Peterson. “Association Between High-Density Lipoprotein Cholesterol With All-Cause Death and Cardiovascular Events in a Primary Prevention Population.” In Circulation, Vol. 136. LIPPINCOTT WILLIAMS & WILKINS, 2017.

Scholars@Duke

Navar, Ann Marie, Robert J. Sanchez, and Eric D. Peterson. “PCSK9 Inhibitors: Patient-Reported Barriers to Medication Initiation and Persistence.” In Circulation, Vol. 136. LIPPINCOTT WILLIAMS & WILKINS, 2017.

Scholars@Duke

Vaduganathan, Muthiah, Amulya Nagarur, Arman Qamar, Ravi B. Patel, Ann Marie Navar, Eric D. Peterson, Deepak L. Bhatt, Gregg C. Fonarow, Clyde W. Yancy, and Javed Butler. “Use of an Open Access Multi-Sponsor Data Sharing Platform in Cardiology.” In Circulation, Vol. 136. LIPPINCOTT WILLIAMS & WILKINS, 2017.

Scholars@Duke

Lowenstern, Angela, Shuang Li, Ann Marie Navar, Salim Virani, Michael J. Louie, L Veronica Lee, Eric D. Peterson, and Tracy Y. Wang. “Statin Decision-Making Since the 2013 AHA/ACC Cholesterol Guidelines: Do Clinicians Do What They Say?” In Circulation, Vol. 136. LIPPINCOTT WILLIAMS & WILKINS, 2017.

Scholars@Duke

Nanna, Michael G., Ann Marie Navar, Tracy Wang, Xiaojuan Mi, Salim Virani, Michael J. Louie, L Veronica Lee, et al. “Statin Utilization and Side Effects Among Adults Over Age 75: Insights From the PALM Registry.” In Circulation, Vol. 136. LIPPINCOTT WILLIAMS & WILKINS, 2017.

Scholars@Duke

Sasson, Comilla, Mary A. Bauman, Vera Bittner, Stephen Daniels, Martha Daviglus, Robert Eckel, and Ann M. Navar. “Key Findings From the AHA Cholesterol Summit.” In Circulation, Vol. 136. LIPPINCOTT WILLIAMS & WILKINS, 2017.

Scholars@Duke

McGarrah, Robert W., Ann M. Navar, Stephanie Giamberardino, Adrian Coles, Lydia C. Kwee, Udo Hoffmann, Geoffrey S. Ginsburg, William E. Kraus, Pamela S. Douglas, and Svati H. Shah. “NMR Lipoprotein Profiling Identifies HDL Subclasses Associated With Obstructive CAD: Insights From the PROMISE Clinical Trial.” In Circulation, Vol. 136. LIPPINCOTT WILLIAMS & WILKINS, 2017.

Scholars@Duke

Lowenstern, Angela, Ann Marie Navar, Shuang Li, Anne C. Goldberg, Michael J. Louie, L Veronica Lee, Salim Virani, Eric D. Peterson, and Tracy Y. Wang. “Associations of Provider Knowledge and Beliefs Regarding Lipid Management With Statin Therapy Use and Lipid Outcomes.” In Circulation, Vol. 136. LIPPINCOTT WILLIAMS & WILKINS, 2017.

Scholars@Duke

Pages